KLB and colonic neoplasm: Evidence suggests that intestinal epithelial cells express receptors that recognize FGF19, such as FGFR4 and β-Klotho, and cultured mouse enteroids respond to FGF19 treatment (40) and inhibition of FGF19 reduced growth and metastasis of colon tumor grafts (41, 42).